SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.214
AS - Asia 5.201
EU - Europa 4.171
SA - Sud America 872
AF - Africa 87
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.973
SG - Singapore 2.205
CN - Cina 1.616
DE - Germania 1.435
BR - Brasile 750
UA - Ucraina 677
IT - Italia 635
HK - Hong Kong 524
RU - Federazione Russa 334
GB - Regno Unito 316
TR - Turchia 306
FI - Finlandia 237
VN - Vietnam 235
PL - Polonia 148
SE - Svezia 137
MX - Messico 115
CA - Canada 99
FR - Francia 89
IN - India 63
ID - Indonesia 52
AR - Argentina 46
NL - Olanda 41
ZA - Sudafrica 39
BD - Bangladesh 38
JP - Giappone 38
ES - Italia 28
EC - Ecuador 25
BE - Belgio 23
IQ - Iraq 20
PK - Pakistan 18
LT - Lituania 14
AT - Austria 13
VE - Venezuela 12
MA - Marocco 11
PY - Paraguay 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
MY - Malesia 8
TN - Tunisia 8
AU - Australia 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IE - Irlanda 7
KE - Kenya 6
PA - Panama 6
SA - Arabia Saudita 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
TH - Thailandia 5
CH - Svizzera 4
EG - Egitto 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
NP - Nepal 4
PS - Palestinian Territory 4
RO - Romania 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JO - Giordania 3
NG - Nigeria 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
PT - Portogallo 1
Totale 19.545
Salva come PNG Salva come JPEG
Città #
Singapore 1.257
Woodbridge 905
Ashburn 873
Chandler 722
Jacksonville 675
Fairfield 604
Santa Clara 543
Beijing 541
Hong Kong 521
Houston 407
Ann Arbor 342
Wilmington 278
Seattle 219
Izmir 206
Nanjing 203
Addison 202
Cambridge 183
Munich 176
New York 170
Los Angeles 163
Princeton 155
Dallas 152
Warsaw 144
Milan 115
San Diego 94
Shanghai 85
Ho Chi Minh City 74
Mexico City 73
São Paulo 71
Shenyang 70
Boardman 66
Helsinki 64
Ferrara 61
Hanoi 56
Hebei 56
Hefei 55
Dearborn 50
Turku 47
Nanchang 46
Tianjin 43
Bremen 39
London 39
Changsha 38
Buffalo 36
Chicago 35
Jakarta 35
Montreal 32
Tokyo 32
Brooklyn 31
Jiaxing 30
Moscow 29
Phoenix 28
Denver 27
Kunming 27
San Francisco 27
Orem 26
Stockholm 26
Falls Church 25
Poplar 25
Washington 25
Chennai 24
Jinan 24
Redwood City 24
Toronto 24
Brussels 23
Mountain View 23
Rome 23
Boston 22
Atlanta 21
Norwalk 21
Rio de Janeiro 21
Johannesburg 20
Bologna 19
Manchester 19
Belo Horizonte 18
Zhengzhou 18
Frankfurt am Main 17
Falkenstein 16
Guangzhou 16
Ningbo 15
Brasília 14
Campinas 14
Council Bluffs 14
San Mateo 14
Ankara 13
Curitiba 13
Modena 13
Auburn Hills 12
Augusta 12
Haiphong 12
Amsterdam 11
Orange 11
Baghdad 10
Mumbai 10
Ottawa 10
Querétaro 10
Quito 10
Taizhou 10
The Dalles 10
Charlotte 9
Totale 12.019
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 282
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 222
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 216
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 205
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 199
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 196
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 189
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 188
Acromegaly is associated with increased cancer risk: a survey in Italy 183
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 175
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 174
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 173
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 172
Growth hormone excess promotes breast cancer chemoresistance 171
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 170
Antiproliferative effects of somatostatin analogs in pituitary adenomas 168
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 166
Diurnal rhythm of plasma catecholamines in acromegaly 166
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 158
Pituitary side effects of old and new drugs. 158
A new VHL polymorphism in a big family from Ferrara 157
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 157
Role of the serotonergic system in the genesis of vasovagal syncope 154
In vitro testing of new somatostatin analogs on pituitary tumor cells 153
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 153
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 153
Cerebral aneurysm and acromegaly: a case report 152
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 152
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 151
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 151
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 151
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 151
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 150
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 150
L’iperplasia surrenale congenita e la pubertà precoce 150
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 149
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 148
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 144
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 144
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 144
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 144
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 143
Functional hypothalamic and drug-induced amenorrhea: an overview 143
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 142
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 142
Le alterazioni pressorie nell'acromegalia: fattori umorali 142
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 141
Glucose metabolism alterations in acromegaly 141
Delta opioid receptor involvement in endocrine pathophysiology 140
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 140
Cerebrovascular disease and GH-IGF-i axis function 137
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 136
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 135
ASSE GH-IGF-I NELL'INVECCHIAMENTO 134
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 134
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 133
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 132
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 130
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 130
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 130
Replacement therapy and quality of life improvement in adult GHD patients 130
null 130
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 128
Prevalence of hypopituitarismin patients with cerebrovascular diseases 126
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 126
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 124
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 121
Systemic illness 120
Human galanin reduces plasma norepinephrine levels in man 120
INVECCHIAMENTO E GH 120
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 120
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 120
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 119
Sistema Simpatoadrenomidollare nei pazienti acromegalici 119
null 118
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 118
Efficay and safety of teriparatide treatment 118
Predictors of morbidity and mortality in acromegaly: An Italian survey 118
Effects of pasireotide on bronchial carcinoids in primary culture 117
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 117
Occurrence of pituitary dysfunction following traumatic brain injury 116
null 114
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 114
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 113
null 113
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy 113
Role of GH-IGF-1 excess on periodontal tissues 113
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 112
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. 112
Acromegaly in the elderly patients 112
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 112
Bariatric surgery in an obese patients with craniopharyngioma 111
null 111
IPOPITUITARISMO E TRAUMA CRANICO. 111
GH-IGF-I deficit 110
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 110
Clinica e diagnostica dei tumori neuroendocrini 109
Tumori neuroendocrini: i meccanismi fisiopatologici 109
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 108
Targeting PKC in human pancreatic neuroendocrine tumor cells 108
Totale 14.154
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.577
Totale 107.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 0 0 0 0 0 147 37 162 31 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/20253.452 99 76 267 106 419 359 129 131 579 428 483 376
2025/20265.044 939 384 800 1.162 1.615 144 0 0 0 0 0 0
Totale 19.743